The Biden Administration has asked a federal appeals court to reconsider a Texas judge’s ruling that voided a Department of [...] …
Month: October 2024
Pfizer’s top executive told investors this week that the 340B program “is one of the biggest issues,” during an earnings [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations, according to notices [...] …
After a long period in which many 340B providers felt helpless, the last month has brought two major wins. First, [...] …
Kalderos, the drug industry vendor behind two 340B claims data submission platforms which support 340B rebates, will file an updated [...] …
A high-profile former Vermont governor with reported drug industry ties took aim at hospitals’ use of 340B savings, calling for [...] …
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year, [...] …
Belgium pharmaceutical giant UCB is extending its 340B contract pharmacy restrictions to all federal grantees and adding new data submission [...] …